Aleglitazar - CISMeF

Preferred Label : Aleglitazar;

NCIt definition : A dual peroxisome proliferator-activated receptor (PPAR) agonist, with hypoglycemic activity. Aleglitazar binds to both PPARalpha and PPARgamma and decreases plasma levels of glucose, LDL-C, triglycerides (TG) and increases HDL levels. This agent may be used for the treatment of diabetes and cardiovascular disease.;

UNII : 41T4OAG59U;

InChIKey : DAYKLWSKQJBGCS-NRFANRHFSA-N;

CAS number : 475479-34-6; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 475479-34-6 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : R1439;

Chemical formula : C24H23NO5S;

Details

Origin ID

C72687;

UMLS CUI

C2348244;

Currated CISMeF NLP mapping
- aleglitazar [MeSH concept]
- aleglitazar [MeSH Supplementary Concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- aleglitazar [MeSH Supplementary Concept]
- aleglitazar [MeSH concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients